Savara
SVRA
#6158
Rank
A$1.56 B
Marketcap
A$7.63
Share price
-2.14%
Change (1 day)
51.42%
Change (1 year)

Earnings for Savara (SVRA)

Earnings in 2026 (TTM): -A$0.2 Billion

According to Savara's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -A$0.17 Billion a decrease over its 2024 earnings that were of -A$0.14 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Savara from 2002 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.2 Billion16.88%
2025 -A$0.17 Billion23.94%
2024 -A$0.14 Billion75.29%
2023 -A$75.99 Million43.38%
2022 -A$53 Million-11.31%
2021 -A$59.76 Million-13.3%
2020 -A$68.92 Million-36.53%
2019 -A$0.11 Billion13.76%
2018 -A$95.46 Million105.54%
2017 -A$46.45 Million34.11%
2016 -A$34.63 Million-37.43%
2015 -A$55.35 Million38.81%
2014 -A$39.87 Million33.62%
2013 -A$29.84 Million38.49%
2012 -A$21.55 Million24.59%
2011 -A$17.3 Million-36.5%
2010 -A$27.24 Million-3.14%
2009 -A$28.12 Million-23.28%
2008 -A$36.65 Million8.52%
2007 -A$33.78 Million-34.14%
2006 -A$51.28 Million184.43%
2005 -A$18.03 Million90.75%
2004 -A$9.46 Million190.35%
2003 -A$3.26 Million11.64%
2002 -A$2.92 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-A$0.32 Billion 76.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-A$25.23 Million-85.98%๐Ÿ‡บ๐Ÿ‡ธ USA